Regarding the SLC6A2 gene, which encodes the norepinephrine transporter (NET), genetic variation has been shown to influence both pharmacodynamics and treatment outcomes in ADHD [48]. Here, SLC6A2 is linked to attention deficit-hyperactivity disorder.